Company OverviewAvalon Globocare Corp.
- Advancing and Empowering Innovative, Transformative Immune Effector Cell Therapy
- Exosome Technology
Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clients’ growth, development, as well as competitiveness in healthcare and CellTech industry markets.
Avalon’s subsidiary and joint venture structure contribute to investor flexibility and R&D focus, enabling Avalon to establish our leading role in the fields of immune effector cell therapy (including CAR-T and CAR-NK), exosome-based regenerative therapeutics (our ACTEXTM platform), as well as "liquid biopsy" diagnostics.
Speaker BioPresident & CEO
Avalon Globocare Corp.
Speaker BioCFO
Avalon Globocare Corp.
Luisa Ingargiola is the CFO of Avalon GloboCare. She is a seasoned executive with over 15 years of experience working in the role of CFO or Audit Chair for multiple public companies. She has significant experience with mergers and acquisitions, corporate governance, internal controls and capital markets. Prior to joining Avalon GloboCare in 2017, Ms. Ingargiola was CFO of MagneGas Corporation (NASDAQ:MNGA). She is currently on the Board of Directors of several public companies including Electra Meccanica (NASDAQ:SOLO) and AgEagle (NASDAQ:UAVS). She received her undergraduate degree in Business Administration from Boston University’s Questrom School of Business, and her Master Degree in Health Administration from the University of S. Florida.
Contact Us
Website:
https://ir.avalon-globocare.com/
Email:
info@avalon-globocare.com
Phone Number:
(1)732-780-4400
